Insider Selling: Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Sells 196 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRGGet Free Report) SVP Mark Brosius sold 196 shares of Intuitive Surgical stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total value of $78,400.00. Following the completion of the transaction, the senior vice president now directly owns 1,842 shares of the company’s stock, valued at $736,800. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Mark Brosius also recently made the following trade(s):

  • On Thursday, March 7th, Mark Brosius sold 196 shares of Intuitive Surgical stock. The shares were sold at an average price of $393.30, for a total value of $77,086.80.
  • On Friday, February 16th, Mark Brosius sold 32 shares of Intuitive Surgical stock. The shares were sold at an average price of $378.29, for a total transaction of $12,105.28.
  • On Wednesday, February 14th, Mark Brosius sold 30 shares of Intuitive Surgical stock. The stock was sold at an average price of $380.09, for a total transaction of $11,402.70.
  • On Monday, February 12th, Mark Brosius sold 30 shares of Intuitive Surgical stock. The shares were sold at an average price of $386.09, for a total transaction of $11,582.70.
  • On Thursday, February 1st, Mark Brosius sold 39 shares of Intuitive Surgical stock. The shares were sold at an average price of $378.41, for a total value of $14,757.99.

Intuitive Surgical Stock Down 0.2 %

Shares of ISRG stock opened at $391.85 on Friday. The firm has a 50 day moving average of $372.99 and a 200-day moving average of $324.65. The company has a market cap of $138.06 billion, a price-to-earnings ratio of 77.90, a price-to-earnings-growth ratio of 6.10 and a beta of 1.36. Intuitive Surgical, Inc. has a 52 week low of $222.65 and a 52 week high of $403.00.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last announced its quarterly earnings data on Tuesday, January 23rd. The medical equipment provider reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.48 by $0.12. The firm had revenue of $1.93 billion for the quarter, compared to analyst estimates of $1.89 billion. Intuitive Surgical had a net margin of 25.24% and a return on equity of 13.11%. The business’s quarterly revenue was up 16.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.91 earnings per share. Analysts anticipate that Intuitive Surgical, Inc. will post 4.93 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. SWP Financial LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth approximately $255,000. Objective Capital Management LLC purchased a new stake in Intuitive Surgical in the 4th quarter valued at $220,000. SageView Advisory Group LLC lifted its stake in Intuitive Surgical by 619.1% during the 4th quarter. SageView Advisory Group LLC now owns 4,926 shares of the medical equipment provider’s stock valued at $1,662,000 after acquiring an additional 4,241 shares in the last quarter. Willner & Heller LLC bought a new position in Intuitive Surgical during the 4th quarter valued at $1,338,000. Finally, Alamar Capital Management LLC boosted its holdings in Intuitive Surgical by 3.8% during the 4th quarter. Alamar Capital Management LLC now owns 4,525 shares of the medical equipment provider’s stock worth $1,527,000 after acquiring an additional 164 shares during the last quarter. Institutional investors and hedge funds own 82.91% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have issued reports on ISRG shares. StockNews.com cut Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Thursday, February 29th. HSBC assumed coverage on shares of Intuitive Surgical in a research note on Friday, November 17th. They issued a “buy” rating and a $318.00 price objective for the company. Raymond James upped their price target on shares of Intuitive Surgical from $372.00 to $435.00 and gave the stock an “outperform” rating in a report on Thursday, January 25th. Stifel Nicolaus boosted their price objective on Intuitive Surgical from $360.00 to $420.00 and gave the stock a “buy” rating in a research report on Wednesday, January 24th. Finally, Morgan Stanley upped their target price on Intuitive Surgical from $300.00 to $330.00 and gave the stock an “equal weight” rating in a report on Monday, December 4th. Five investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $371.60.

Read Our Latest Analysis on ISRG

Intuitive Surgical Company Profile

(Get Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Further Reading

Insider Buying and Selling by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.